Second Circuit Blocks DOJ Trans Medical Records Subpoena

• The Second Circuit Court of Appeals upheld a lower court's injunction blocking the Department of Justice from seizing medical records related to gender-affirming care for transgender youth.
• This ruling prevents the federal government from accessing sensitive patient data, including diagnoses and treatment plans, that was sought via grand jury subpoenas issued to over 20 New York healthcare facilities.
• U.S. District Judge Katherine Failla had previously found that the plaintiffs, transgender patients and their families, would likely suffer irreparable harm and succeed in claims under New York confidentiality laws.
• The subpoenas originated from Trump administration directives, including an executive order against funding gender-affirming care for minors and an Attorney General's probe into drug companies for "misbranding."
• This decision reinforces patient privacy rights and aligns with a national trend where federal courts have quashed or limited similar broad government subpoenas for medical records.

This decision by the Second Circuit, blocking the Department of Justice's access to sensitive transgender patient medical records, reinforces the critical importance of patient privacy rights, particularly within the context of gender-affirming care.

The Second Circuit Court of Appeals recently upheld a lower court's decision to block the U.S. Department of Justice's attempt to obtain sensitive medical records related to gender-affirming care. This ruling denied the Justice Department's request to stay a preliminary injunction that had previously halted the administration's efforts to seize these records. The appellate panel, which included U.S. Circuit Judges Richard J. Sullivan and William J. Nardini, both appointed by Donald Trump, alongside U.S. Circuit Judge Alison J. Nathan, a Joe Biden appointee, issued a concise order stating, "Upon due consideration, it is hereby ordered that the motion is denied," without further elaboration.

This appellate decision affirms a July preliminary injunction issued by U.S. District Judge Katherine Failla, who had initially granted a temporary restraining order. The injunction stemmed from a lawsuit filed by transgender patients and their families against the Justice Department and U.S. Attorney General Todd Blanche. Federal prosecutors had previously issued grand jury subpoenas to more than 20 healthcare facilities, seeking detailed information about gender-affirming care provided to trans youth since 2020. The requested data included patients' diagnoses, assessments, and specific courses of treatment.

The plaintiffs in the case comprise two young adults and three minors, whose families are pursuing legal action on their behalf. All these individuals were minors when they received gender-affirming care at New York City hospitals during the period under scrutiny. The legal challenge, supported by organizations such as Lambda Legal, the American Civil Liberties Union, and the New York Civil Liberties Union, directly confronted the federal government's broad demand for private medical information.

District Judge Failla, an appointee of Barack Obama, determined that the plaintiffs would likely suffer irreparable harm if the court did not intervene to protect their medical privacy. Her ruling also indicated a strong likelihood that the plaintiffs would succeed in claims against NYU Langone, which was named as a co-defendant and was among the healthcare facilities targeted by the government's subpoenas. These potential claims are based on New York's robust confidentiality laws, underscoring the state-level protections for patient data.

The grand jury subpoenas for medical records emerged from a broader federal initiative during the Trump administration targeting gender-affirming care. On January 28, 2025, President Donald Trump issued an executive order declaring that the United States would "not fund, sponsor, promote, assist or support" gender-affirming medical care for minors. Following this, in April 2025, then-Attorney General Pam Bondi directed the Justice Department’s civil division to launch an investigation into pharmaceutical companies.

This probe focused on manufacturers and distributors of puberty blockers and sex hormones, examining potential violations of the Food, Drug and Cosmetic Act, specifically concerning "misbranding" through false claims about on- or off-label uses of these drug therapies. Attorney General Bondi articulated the administration's stance, stating that "Even if otherwise truthful, the promotion of off-label uses of hormones — including through informal campaigns like those conducted by sales reps or under the guise of sponsored continuing medical education courses — run afoul of the FDA’s prohibitions on misbranding and mislabeling." This directive laid the groundwork for the subsequent grand jury subpoenas that sought patient-specific information from healthcare providers.

This decision by the Second Circuit, blocking the Department of Justice's access to sensitive transgender patient medical records, reinforces the critical importance of patient privacy rights, particularly within the context of gender-affirming care. The ruling sends a clear message that government entities cannot easily weaponize legal tools like grand jury subpoenas to broadly collect highly personal health information, especially when such actions could infringe upon constitutional privacy guarantees. Omar Gonzalez-Pagan, senior counsel at Lambda Legal, emphasized this point, stating that the government should not use the legal system to gather private medical data of transgender young people and their families, as this violates the right to privacy. He further asserted that all families should be able to make healthcare decisions free from political interference or public exposure.

The legal challenges to these subpoenas are not isolated incidents; similar information requests have faced lawsuits across the country, prompting courts to scrutinize the boundaries of medical privacy laws. In numerous states, federal courts have either quashed or significantly limited the scope of such subpoenas, indicating a broader judicial trend towards protecting patient confidentiality against expansive government demands. This particular ruling, centered on NYU Langone medical privacy lawsuit implications, adds significant precedent within the Second Circuit, strengthening the position of healthcare providers who resist broad government inquiries into patient medical histories, especially those involving gender-affirming care. The Justice Department did not provide an immediate comment on the Second Circuit's decision.

This ruling strengthens the legal basis for healthcare providers, particularly those offering gender-affirming care, to resist broad government subpoenas for patient medical records, especially within the Second Circuit. Lawyers advising such providers should be aware of this precedent when responding to similar information requests.

Source: Original reporting via Courthouse News Service